Why Invest in Fidelity Select Biotechnology Portfolio (FBIOX)?
Fidelity Select Biotechnology Portfolio (FBIOX) seeks capital appreciation. It normally invests at least 80% of assets in common stocks of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology.
This Sector - Health product has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 11.1% and 5 year 21%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.
FBIOX’s performance, as of the last filing, when compared to funds in its category was in the top 12% over the past 1 year, and in the top 40% over the past 3 years and in the top 3% over the past 5 years.
This Zacks Rank #2 (Buy) was incepted in December 1985 and is managed by Fidelity. FBIOX carries an expense ratio of 0.75% and requires a minimal initial investment of $2,500.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
View All Zacks #1 Ranked Mutual Funds
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Get Your Free (FBIOX): Fund Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
